Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-12

Clinical Trial Update: A Study of HBS-201 (Pitolisant Delayed-release) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating HBS-201 (delayed-release pitolisant) for narcolepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HBS-201 (Pitolisant Delayed-release) (pitolisant)

Snippet

Sponsor: Harmony Biosciences Management, Inc. | Conditions: Narcolepsy | Phase 1 | Status: COMPLETED